Search Results - "Nilsson, Povl"

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    Pharmacokinetics and Safety of FFR-rFVIIa after Single Doses in Healthy Subjects by Erhardtsen, Elisabeth, Nilsson, Povl, Johannessen, Marie, Thomsen, Mikael S.

    Published in Journal of clinical pharmacology (01-08-2001)
    “…FFR‐rFVIIa is an antithrombotic agent, which has also proven to have antirestenotic properties in animal models. FFR‐rFVIIa is a modified recombinant FVIIa in…”
    Get full text
    Journal Article
  2. 2

    Monokine antagonism is reduced in patients with IDDM by Mandrup-Poulsen, T, Pociot, F, Mølvig, J, Shapiro, L, Nilsson, P, Emdal, T, Røder, M, Kjems, L L, Dinarello, C A, Nerup, J

    Published in Diabetes (New York, N.Y.) (01-10-1994)
    “…Interleukin-1 (IL-1) and tumor necrosis factor alpha (TNF-alpha) have been implicated as immune effector molecules in the pathogenesis of insulin-dependent…”
    Get full text
    Journal Article
  3. 3

    Properties of the Scrapie Prion Protein: Quantitative Analysis of Protease Resistance by Oesch, Bruno, Jensen, Margit, Nilsson, Povl, Fogh, Jens

    Published in Biochemistry (Easton) (17-05-1994)
    “…The disease-specific isoform of the prion protein (PrP(Sc)) is an essential part of the infectious particle which causes spongiform degeneration in various…”
    Get full text
    Journal Article
  4. 4

    Circulating interleukin-1 receptor antagonist concentrations are increased in adult patients with thermal injury by Mandrup-Poulsen, Thomas, Wogensen, Lise D, Jensen, Michael, Svensson, Preben, Nilsson, Povl, Emdal, Thorkil, Molvig, Jens, Dinarello, Charles A, Nerup, Jorn

    Published in Critical care medicine (01-01-1995)
    “…OBJECTIVETo investigate the balance between circulating concentrations of interleukin (IL)-1 and its natural inhibitor interleukin-1 receptor antagonist…”
    Get full text
    Journal Article
  5. 5

    Pharmacokinetics of recombinant factor VIIa in the rat--a comparison of bio-, immuno- and isotope assays by Thomsen, M K, Diness, V, Nilsson, P, Rasmussen, S N, Taylor, T, Hedner, U

    Published in Thrombosis and haemostasis (1993)
    “…Recombinant human factor VIIa (rFVIIa) is an activated coagulation factor for intravenous use as a haemostatic agent in haemophiliacs who generate antibodies…”
    Get more information
    Journal Article
  6. 6

    Accumulation of the recombinant factor VIIa in rat bone: importance of the Gla-domain and relevance to factor IX, another vitamin K-dependent clotting factor by Thomsen, M K, Wildgoose, P, Nilsson, P, Hedner, U

    Published in Pharmacology & toxicology (01-09-1993)
    “…The vitamin K-dependent clotting factors II, VII, IX, and X are proteins which undergo gamma-carboxylation of specific glutamic acid residues prior to…”
    Get more information
    Journal Article
  7. 7

    Pharmacological characterization of a biosynthetic trisulfide-containing hydrophobic derivative of human growth hormone: comparison with standard 22 K growth hormone by Thomsen, M K, Hansen, B S, Nilsson, P, Nowak, J, Johansen, P B, Thomsen, P D, Christiansen, J

    Published in Pharmacology & toxicology (01-06-1994)
    “…Growth hormone is the classical anabolic hormone which promotes organ growth after binding to somatogenic target cell receptors, present in various target…”
    Get more information
    Journal Article